People · Operator
Named in public records as an officer, director or promoter · active 2011–2023 · Medical Devices, Biotechnology, Other, Pharmaceuticals, Other Energy, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Think Surgical, Inc. | — | Medical Devices | Series D+ | $139.6M | $88.5M | 2022 |
| Chroma Medicine, Inc. | — | Biotechnology | Series D+ | $135.0M | $2.3B | 2023 |
| FS OneEquity Partners Co. L.P. | — | Other | Series C | $55.7M | $53.3M | 2016 |
| HOOKIPA Pharma Inc. | — | Pharmaceuticals | Series B | $37.4M | $1.3B | 2019 |
| Upwind Solutions Inc | — | Other Energy | Series A | $30.0M | $105.7M | 2012 |
| Myotherix, Inc. | — | Biotechnology | Series A | $9.4M | $286.7M | 2015 |
| FINEOS Corp Holdings PLC | — | Other Technology | Series A | $8.3M | $218.3M | 2020 |
| Moprise, Inc. | — | Other Technology | Seed | $2.3M | $59.2M | 2011 |
| Banyan Branch, Inc. | — | Other Technology | Seed | $1.7M | $59.2M | 2011 |
| FullStack Inc | — | Other | Pre-Seed | $960K | $8.0M | 2019 |
| Yourco, Inc. | — | Other Technology | Pre-Seed | $512K | $5.3M | 2021 |
Michael Kelly at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Kelly on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| GEOFFREY ENTRESS | 2 | 4 |
| ALEJANDRO GARCIA | 2 | 2 |
| DAVID HANLEY | 2 | 2 |
| BLAKE CAHILL | 2 | 2 |
| Kevin Bitterman | 1 | 15 |
| Mark Lewis | 1 | 15 |
| BIHUA CHEN | 1 | 14 |
| Mark De Souza | 1 | 10 |
| John Brennan | 1 | 9 |
| Mark P. De Souza | 1 | 7 |
| Richard Vague | 1 | 5 |
| Michael Linse | 1 | 5 |
| Jak Knowles | 1 | 4 |
| John Fry | 1 | 4 |
| David Hollander | 1 | 3 |
| Graziano Seghezzi | 1 | 3 |
| Michael Kelley | 1 | 3 |
| Michael A. Kelly | 1 | 3 |
| Michael P Kelly | 1 | 3 |
| David Mount | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.